ArticleFrontiers in molecular biosciences2023

Potent VEGFR-2 inhibitors for resistant breast cancer: a comprehensive 3D-QSAR, ADMET, molecular docking and MMPBSA calculation on triazolopyrazine derivatives.

Soukayna Baammi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.